Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
Safety monitoring and epidemiological surveillance of blood transfusion in the United States is complex and involves government agencies and independent organizations. Several systems of control are in place nationwide to ensure that blood, blood components, and plasma derivatives meet prescribed standards. Control and surveillance of drugs that are biologics, which include human blood, blood components and plasma derivatives, are exercised by the Food and Drug Administration. Epidemiological surveillance involves several agencies and organizations that constitute a network capable of rapidly detecting unusual adverse events.